Identity
- Trade Name
- ACCURUN® FDA UDI
- Generic Name
- SARS-CoV-2 nucleic acid IVD, control FDA UDI
- Model / Reference
- 0505-0227 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00816784020086 FDA UDI
- GMDN Term
- SARS-CoV-2 nucleic acid IVD, control FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: SARS-CoV-2 nucleic acid IVD, control
Accurun® by LGC Clinical Diagnostics, Inc. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as SARS-CoV-2 nucleic acid IVD, control.
- Aptima® — Hologic, Inc. · Class II
- RealTime — Abbott Molecular · N
- NATtrol™ — ZeptoMetrix LLC · Class I
- NATtrol™ — ZeptoMetrix LLC · Class I
- Simplexa COVID-19 Direct — DiaSorin Molecular LLC · Class II
- Exact Diagnostics — Exact Diagnostics · Class I
- Helix Elite™ Molecular Standards: Synthetic Standard — MICROBIOLOGICS, INC. · Class I
- ID NOW COVID-19 2.0 Control Swab Kit — Alere Scarborough, Inc. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- LGC Clinical Diagnostics, Inc.
Sources (1)
- FDA UDI 0d0706cb-e8e9-4033-aff9-320f255fdb62 32 fields · synced Jun 9, 2026